Chemoinformaics analysis of 2,5-DIMETHYLTHIOPHEN-3-CARBOXYALDEHYDE
| Molecular Weight | 140.207 | nRot | 1 |
| Heavy Atom Molecular Weight | 132.143 | nRig | 6 |
| Exact Molecular Weight | 140.03 | nRing | 1 |
| Solubility: LogS | -2.414 | nHRing | 1 |
| Solubility: LogP | 2.35 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 17 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 5 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 5 |
| nHA | 2 | APOL | 20.7263 |
| nHD | 0 | BPOL | 11.3537 |
| QED | 0.546 |
| Synth | 2.715 |
| Natural Product Likeliness | -0.887 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.001 |
| HIA | 0.003 |
| CACO-2 | -4.294 |
| MDCK | 0.0000286 |
| BBB | 0.846 |
| PPB | 0.852849 |
| VDSS | 1.286 |
| FU | 0.122947 |
| CYP1A2-inh | 0.942 |
| CYP1A2-sub | 0.867 |
| CYP2c19-inh | 0.677 |
| CYP2c19-sub | 0.821 |
| CYP2c9-inh | 0.086 |
| CYP2c9-sub | 0.795 |
| CYP2d6-inh | 0.024 |
| CYP2d6-sub | 0.704 |
| CYP3a4-inh | 0.022 |
| CYP3a4-sub | 0.331 |
| CL | 6.944 |
| T12 | 0.295 |
| hERG | 0.007 |
| Ames | 0.138 |
| ROA | 0.022 |
| SkinSen | 0.252 |
| Carcinogencity | 0.092 |
| EI | 0.996 |
| Respiratory | 0.957 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.916172 |